Product of the week

ELIQUIS (apixaban), an oral direct factor Xa inhibitor, is now PBS listed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE, in adult patients.